Literature DB >> 15551572

Integrating sphere effect in whole bladder wall photodynamic therapy: I. 532 nm versus 630 nm optical irradiation.

H J van Staveren1, J F Beek, J W Ramaekers, M Keijzer, W M Star.   

Abstract

The optical absorption, scattering and anisotropy coefficients of piglet bladder, with and without Photofrin, and of diseased human bladder were determined in vitro with a double integrating sphere set-up in the wavelength range 450-800 nm. Monte Carlo simulations were performed in a spherical geometry, representing the bladder, using the optical properties at 532 nm and 630 nm determined in vitro. The calculated fluence rates support the fluence rates that were measured at the bladder wall of a piglet during an in vivo whole bladder wall (WBW) irradiation at 532 nm and 630 nm. Fluence rates calculated and measured in vivo at 630 nm are in agreement with those measured previously in clinical photodynamic therapy (PDT) at 630 nm. WBW-PDT with red light (630 nm) will be technically more advantageous than with green light (532 nm) because of a stronger integrating sphere effect, which reduces the variations of the fluence rate at the bladder wall when the isotropic light source is moved away from the centre of the bladder. Since the optical properties show considerable variations from bladder to bladder, and since as a result the light fluence rate at the bladder wall can vary by a factor of 3 to 4 for the same non-scattered light fluence rate, we conclude that in situ light dosimetry during clinical WBW-PDT is a necessity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 15551572     DOI: 10.1088/0031-9155/39/6/003

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  8 in total

1.  An indwelling brachytherapy balloon catheter: potential use as an intracranial light applicator for photodynamic therapy.

Authors:  H Hirschberg; S Madsen; K Lote; T Pham; B Tromberg
Journal:  J Neurooncol       Date:  1999-08       Impact factor: 4.130

Review 2.  A review of in-vivo optical properties of human tissues and its impact on PDT.

Authors:  Julia L Sandell; Timothy C Zhu
Journal:  J Biophotonics       Date:  2011-11       Impact factor: 3.207

3.  Photodynamic therapy as adjuvant therapy in surgically treated pleural malignancies.

Authors:  P Baas; L Murrer; F A Zoetmulder; F A Stewart; H B Ris; N van Zandwijk; J L Peterse; E J Rutgers
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

4.  Timing of illumination is essential for effective and safe photodynamic therapy: a study in the normal rat oesophagus.

Authors:  J van den Boogert; R van Hillegersberg; H J van Staveren; R W de Bruin; H van Dekken; P D Siersema; H W Tilanus
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

5.  Minimal required PDT light dosimetry for nonmuscle invasive bladder cancer.

Authors:  Lothar Lilge; Jenny Wu; Yiwen Xu; Angelica Manalac; Daniel Molehuis; Fynn Schwiegelshohn; Leonid Vesselov; Wayne Embree; Michael Nesbit; Vaughn Betz; Arkady Mandel; Michael A S Jewett; Girish S Kulkarni
Journal:  J Biomed Opt       Date:  2020-06       Impact factor: 3.170

6.  Effects of patient-specific treatment planning on eligibility for photodynamic therapy of deep tissue abscess cavities: retrospective Monte Carlo simulation study.

Authors:  Zihao Li; Lam Nguyen; David A Bass; Timothy M Baran
Journal:  J Biomed Opt       Date:  2022-02       Impact factor: 3.170

7.  Response of Photofrin-sensitised mesothelioma xenografts to photodynamic therapy with 514 nm light.

Authors:  T H Foster; S L Gibson; R F Raubertas
Journal:  Br J Cancer       Date:  1996-04       Impact factor: 7.640

8.  Antimicrobial photodynamic therapy mediated by methylene blue and potassium iodide to treat urinary tract infection in a female rat model.

Authors:  Ying-Ying Huang; Anton Wintner; Patrick C Seed; Timothy Brauns; Jeffrey A Gelfand; Michael R Hamblin
Journal:  Sci Rep       Date:  2018-05-08       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.